Search research articles
Contact Us
Filters
Showing results (221-230 of 351) with videos related to
Page
of 36
Sort By:
Arthritis Care & Research
|
November 10, 2025
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)
Madeline L O'Sullivan, Grant W Cannon, Brian C Sauer, et al.
RMD Open
|
January 30, 2026
Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial
Josef S Smolen, Ted R Mikuls, James Galloway, et al.
The American Journal of Medicine
|
December 4, 2018
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
Ted R Mikuls, T Craig Cheetham, Gerald D Levy, et al.
Arthritis Care & Research
|
April 21, 2017
Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis
Bryant R England, Joshua F Baker, Harlan Sayles, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
December 12, 2023
Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner
Jill A Poole, Geoffrey M Thiele, Elizabeth Ramler, et al.
Redox Biology
|
August 14, 2017
Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging
Matthew C Zimmerman, Dahn L Clemens, Michael J Duryee, et al.
Arthritis Care & Research
|
June 29, 2012
Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis
J Steuart Richards, Grant W Cannon, Candace L Hayden, et al.
Plos One
|
September 12, 2014
Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease
Daniel R Anderson, Michael J Duryee, Scott W Shurmur, et al.
Rheumatology (Oxford, England)
|
September 2, 2024
Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
Josef S Smolen, Peter C Taylor, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 29, 2024
The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rebecca T Brooks, Brent Luedders, Austin Wheeler, et al.
Page
of 36
Search research articles
Search
Showing results (221-230 of 351) with videos related to
Sort By:
Page
of 36
Arthritis Care & Research
|
November 10, 2025
Mortality in US Veterans with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors (ICIs)
Madeline L O'Sullivan, Grant W Cannon, Brian C Sauer, et al.
RMD Open
|
January 30, 2026
Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial
Josef S Smolen, Ted R Mikuls, James Galloway, et al.
The American Journal of Medicine
|
December 4, 2018
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
Ted R Mikuls, T Craig Cheetham, Gerald D Levy, et al.
Arthritis Care & Research
|
April 21, 2017
Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis
Bryant R England, Joshua F Baker, Harlan Sayles, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
December 12, 2023
Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner
Jill A Poole, Geoffrey M Thiele, Elizabeth Ramler, et al.
Redox Biology
|
August 14, 2017
Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging
Matthew C Zimmerman, Dahn L Clemens, Michael J Duryee, et al.
Arthritis Care & Research
|
June 29, 2012
Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis
J Steuart Richards, Grant W Cannon, Candace L Hayden, et al.
Plos One
|
September 12, 2014
Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease
Daniel R Anderson, Michael J Duryee, Scott W Shurmur, et al.
Rheumatology (Oxford, England)
|
September 2, 2024
Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
Josef S Smolen, Peter C Taylor, Yoshiya Tanaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 29, 2024
The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rebecca T Brooks, Brent Luedders, Austin Wheeler, et al.
Page
of 36